Benitec Biopharma Inc
NASDAQ:BNTC
During the last 3 months Benitec Biopharma Inc insiders bought 2.1m USD , and have not sold any shares. The stock price has increased by 3% over this period (open performance analysis).
The last transaction was made on
Dec 29, 2025
by
Suvretta Capital Management, Llc
, who
bought
884.4k USD
worth of 
BNTC shares.
During the last 3 months Benitec Biopharma Inc insiders bought 2.1m USD , and have not sold any shares. The stock price has increased by 3% over this period (open performance analysis).
The last transaction was made on
Dec 29, 2025
by
Suvretta Capital Management, Llc
, who
bought
884.4k USD
worth of BNTC shares.
Benitec Biopharma Inc
Glance View
Benitec Biopharma, Inc. is a development-stage biotechnology company, which focuses on the advancement of novel genetic medicines. The company is headquartered in Hayward, California and currently employs 14 full-time employees. The company went IPO on 2012-07-11. The firm is focused on developing a therapeutic technology platform that combines ribonucleic acid (RNA) interference with gene therapy for the goal of silencing disease-causing genes from a single administration. The firm's technology, deoxyribonucleic acid (DNA)-directed RNA interference (ddRNAi), is used to develop product candidates in chronic and life-threatening human disease areas including orphan disease and infectious disease. Its pipeline includes BB-301, and BB-103. The firm's lead product candidate, BB-301, is used for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD). Its BB-103 pipeline product is being developed for the treatment of chronic hepatitis B Virus infection.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
